Johnson and Johnson Vs. Lupin Limited and Anr

Decided On : Feb-27-2015

Court : Delhi

LAW: Order 39 Rule 1, Section 151, Drugs and Cosmetic Act, Order 39 Rule 1, the Full Bench, the Division Bench, Section 11, the Full Bench, Section 29(4, the Trade Marks Act, Section 151

DATE: February, 2015, 1931/2012, the year 1886, the year 1957, today, last more than 50 years, the year 2008, 20th November, 2008, 22nd June, 2009, the August 2011, the year 2011, 2012, the years, 29th October, 2008, the year 2009, the month of March 2012, 20th August, 2010, September/October, 2011, October, 2011, August, 2010, 18th July, 2012, October, 2011, 20th August, 2010, 2011950, 8th August, 2011, 2nd September, 2011, 2199474, 6 th July, 2012, 16th July, 2012, 12th September, 2012, 18th July, 2012, 16th July, 2012, 2008, 22nd January, 2008, 29th October, 2008, 29th October, 2008, 28th November, 2008, 22nd June, 2009, 17th May, 2011, October, 2010, 17th May, 2011, 30th August, 26th August, September/October, 2011, 20th August, 2010, January, 2008, June 2009, 26th July, 2012, 23rd December, 2014, October, 2011, 26th July, 2013, August, 2013, 26th July, 2012, 10th October, 2013, 4th July, 2012, 28th January, 2013, 8th January, 2013, 2007, recent years, 1996, 1996, 1999, 1967, 1974, 1901, 1964, 1985, 1956, 1993, 1901, 1896, 1994, 1995, 2004, the year 2004, 2014, one good day, the modern day, 15th March 2010, 2006, 15th March 2010, 2006, 2002, October, 29th October, 2008, 1999, 2001, para 28, 30, 32, 1954, 101, USPQ44 47, 48, 1955, 1971, 2010, 2010, 1995, 1998, 1999, 32, 1987, the last many years, October, 2011, 2nd September, 2011, 44, Others 2004, 2012, 2004, 1946, the month of May, 2012, October, 2011, about 8 months, July, 2012, October, 2011, three months, 1931/2012 59, 20th April, 2015, 2015

GPE: CS(OS, USA, India, India, India, USA, Canada, USA, USA, India, India, India, Delhi, CS(OS, India, Bombay, Bombay, Bombay, Bombay, India, CS(OS, USA, USA, India, India, India, U.S.A, India, USA, U.S.A., US, USA, US, USA, US, I.A., India, Bombay, India, India, India, India, India, India, India, India, India, India, India, CS(OS, India, India, Canada, India, India, India, India, India, India, India, India, India, India, India, India, India, India, India, India, India, India, D.C., India, India, India, Smithkline, India, India, India, India, India, India, India, India, India, India, India, India, India, India, India, India, India, CS(OS

ORG: JOHNSON & JOHNSON Through, ANR, I.A. No.11918/2012, CPC, State of New Jersey, Plaintiff, Johnson & Johnson Limited, NUCYNTA, Janssen Pharmaceuticals Inc., the New Drug Application, NDA, NUCYNTA, United States Food and Drug Administration, FDA, NUCYNTA, FDA, NUCYNTA ER, NUCYNTA CR, NUCYNTA, NUCYNTA, NUCYNTA, NUCYNTA, NUCYNTA, NUCYNTA, NUCYNTA, NUCYNTA, NUCYNTA, NUCYNTA, No.2199474, LUCYNTA, LUCYNTA, LUCYNTA, No.2011950, LUCYNTA, NUCYNTA, LUCYNTA, NUCYNTA, NUCYNTA, LUCYNTA, the Trade Marks Journal, LUCYNTA, NUCYNTA, LUCYNTA, LUCYNTA, NUCYNTA, Lodging No.1842/2012, the Bombay High Court, LUCYNTA, LUCYNTA, LUCYNTA, LUCYNTA, LUCYNTA, the Trade Marks Journal, NUCYNTA, LUCYNTA, LUCYNTA, LUCYNTA, LUCYNTA, No.2, LUCYNTA, THE WRITTEN STATEMENT9, LUCYNTA, NUCYNTA, LUCYNTA, Court, Court, NUCYNTA, LUCYNTA, LUCYNTA, No.1931/2012 Inc., the Unites States Food and Drug Administration, FDA, NUCYNTA, FDA, NUCYNTA, NUCYNTA, NUCYNTA, NUCYNTA, NUCYNTA, Yale Journal of Biology and Medicine, Journal of Anaesthesiology Clinical Pharmacology, International Journal of Pharma & Bio Sciences, Indian Journal, NUCYNTA, www.medindia.net.14, No.2011950, NUCYNTA, LUCYNTA, US FDA, NUCYNTA, Lupin Pharmaceuticals Inc., U.S Food and Drug Administration, U.S Food and Drug Administration, Lupin Pharmaceuticals Inc., US Department of Health and Human Services, CPC, NUCYNTA, LUCYNTA, NUCYNTA, TRANSDOL, Mumbai High Court, Suit, L.D.G., High Court, inter alia, the Intellectual Property Appellate Board, the Civil Court, Court, Court, NUCYNTA, NUCYNTA, LUCYNTA, NUCYNTA, Court, TRANSDOL, NUCYNTA, India.22, NUCYNTA, NUCYNTA, LUCYNTA, NUCYNTA, Bombay High Court, Plaintiff, Plaintiff, Bombay High Court, NUCYNTA, LUCYNTA, NUCYNTA, Bombay High Court, LUCYNTA, NUCYNTA, Reliance, Trans-Border Reputation 29, Kerly’s, Law of Trade Marks and Trade Names (Fourteenth Edition, Plaintiff, Defendants, the Division Bench, Court, N.R.Dongre v. Whirlpool Corporation, immaterial”.33, Whirlpool, the Supreme Court, N.R. Dongre and Ors, Court, Whirlpool, Allergan Inc., Milment Oftho Industries, Others Court, Cie v. Pavilion Properties, Levassor v. Panhard Motor Co. Ltd., McCain Foods, IRC, Rose & Thistle, Calvin Klein Inc., International Apparels, Conagra Inc., McCain Foods (Supra, Kolkata High Court, Supreme Court, Milment Oftho Industries, Allergan Inc., the Supreme Court, Respondents, Indian Company, the Indian Company, Respondents, Division, Respondents, Respondents, Cadbury U.K. Limited & Anr, Lotte India Corporation Ltd., Cadbury UK Limited, Plaintiff, Plaintiff, Court, Court, CS, Roca Sanitario S.A., Court, CS, Roca Sanitario S.A., the Supreme Court, the Supreme Court, NUCYNTA, NUCYNTA, LUCYNTA, NUCYNTA, NUCYNTA, www.wikipedia.com.40, LUCYNTA, Court, Court, LUCYNTA, Reliance, Court, Bombay High Court, Cadila Health Care Ltd., Cadila Pharmaceuticals Ltd., Supreme Court, Morgenstern Chemical Company's, Cole Chemical Co., the Patent Office, R.J.Strasenburgh Co., Kenwood Laboratories INC, Syntex Laboratories Inc. Vs, Norwich Pharmacol Co., 3rd Edition, Roca Sanitario S.A., Naresh, Chorion Rights Ltd., M/s Ishan Apparel & Ors, Cluett Peabody & Co. Inc., Beecham Plc, M/s, Hindustan Lever Limited & Ors, R.J.Reynods Tobacco Company, Indian Tobacco Company Ltd., NUCYNTA, Chorion Rights Ltd., Cluett Peabody & Co., the Supreme Court, Whirlpool, Smithkline Beecham Plc, R.J.Reynolds Tobacco Company, LUCYNTA, No.2199474, LUCYNTA, Reliance, Supreme Court, TRANSDOL, LUCYNTA, LUCYNTA, NUCYNTA, LUCYNTA, Reliance, Alferd Dunhill Limited, NUCYNTA, TRANSDOL, LUCYNTA, LUCYNTA, NUCYNTA, Midas Hygiene Industries Pvt, Hindustan Pencils Pvt. Ltd., M/s India Stationery Products Co., J.R. Parkingnon and Co. Ltd., Bengal Waterproof Ltd., M/s. Bombay Waterproof Manufacturing Co., NUCYNTA, LUCYNTA, LUCYNTA, NUCYNTA, CPC, LUCYNTA

PERSON: Sudhir Chandra, Deepak, Priya Rao, Kirti Uppal, Alka Parelkar, Varun Singh, Anuj Sharma, Anshumaan Sahni, MANMOHAN SINGH MANMOHAN, Tapentadol, Tapentadol, Ortho-McNeilJanssen Pharmaceuticals, Tapentadol, vii, viii, Tapentadol, No.2.10, Ortho-McNeilJanssen Pharmaceuticals, Janssen Page 8, Tapentadol, Janssen Pharmaceuticals, Tapentadol, Tapentadol Hydrochloride, Tapentadol, mark and/or, No.1’s, vii, viii, Kirti Uppal, Uppal, Uppal, Uppal, Roshan Lal Duggar Co., Goodwill, Goodwill, Whirlpool Corpn, Anr, Eurway Int, Sheraton Corpn, Sheraton Motels, Tnd. v. Pest Co., Vitamins L. D.'s, Goodwill, Muller, AC217 Trego, Hunt, AC7 ITC, B.C. Srinivas Shetty, N.R. Dongre v. Whirlpool Corporation, J.N. Nichols, Appellants, Whirlpool, Kumar Gupta, Kumar Gupta, Laxmikant V. Patel, Chetanbhat Shah, V. Patel, Tapentadol, Helen, Leeds, McCarthy, Uppal, Kumar Gupta, Anr, Arrow Apparels, Roca, Roca, Sudhir Chandra, Oftho, Sudhir Chandra, Tapentadol Hydrochloride, R.P.S. Chawla, Delhi Luxury Tours, Tapentadol Hydrochloride, Sudhir Bhatia, Romer, J.in, AIR1997SC1398it, Order XXXIX Rule 1

NORP: J.1, Indian, Indian, Indian, South Asian, Canadian, Indian, Indian, Indian, RAJ634(Del

CARDINAL: 2, at least 250, 57, 3.7, 5, 5, 4, 37, one, 7.1, five, 7.2, 7.4, No.2, No.2, No.2, 37, 19, 2011, 2011, five, No.1, two, two, 29, 29, 25, 22, 29, 26, 29, 28, 250, 14, One, one, 300, 2, 19, 160, one, 18, 5, 433, 1, 23, 133, 34, 12, one, 35, 57, 33, 33, 626, one, 626, one, 37, 3, two, 38, 2011.39, 31, 5, 28, 5, 118F., 612, 616, 617, 106, 380, 23.12, 7, 43, 18, 18, 19, more than 80, two, two, 8).48, 29, 6, 51, 23).50, one, 28, 19, 63, 181, 2

MONEY: more than $ 290 million, more than US $ 650 million, two marks, 169 USPQ12nd, two marks

PRODUCT: No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, No.1, the Full Bench, No.1, No.1, No.1, No.1, No.1, Para 10, No.1, No.1, No.1, No.1, Cole, No.1, No.1, No.1, No.1, No.1, No.1, No.1

WORK_OF_ART: Recent Advances in Postoperative Pain Management, Pharma Science Monitor, 32nd Edition, LUCYNTA, NUCYNTA, LUCYNTA, NUCYNTA, Century Traders, NUCYNTA, Google

ORDINAL: 4th, first, first, Secondly, 7th, third, first, second, first, second, third, first, first, first, first, Firstly, Secondly, first

LOC: Registrar

FAC: Roster Bench